GSK Class Action News: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Involving GSK PLC
SAN DIEGO, CA / ACCESS Newswire / February 10, 2025 / Robbins LLP reminds stockholders that a class action was filed on ...
TMCnet1d
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages GSK plc. (GSK) Investors To Inquire About Securities Fraud Class Action
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise ...
Hosted on MSN2mon
GSK's belantamab mafodotin reduced death risk by 42% in study
GSK (NYSE:GSK) reported that a study showed its drug belantamab mafodotin was able to reduce the risk of death by 42% in patients with multiple myeloma at or after first relapse.
Hosted on MSN6mon
GSK shingles vaccine cuts dementia risk
GSK (NYSE:GSK) announced Tuesday that its shingles vaccine, Shingrix, reduced the risk of dementia with a statistically significant effect compared to Merck's (MRK) pneumonia vaccine, Pneumovax 23 ...